Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians

Toon andere (1) versies

Attention deficit/hyperactivity disorder (ADHD) is a common disorder and a plethora of new data has been published from clinical trials and national epidemiological databases in the last three years. In the United Kingdom Atomoxetine is currently the only licensed non-stimulant medication. As part o...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Chris J. Bushe Mbbs, Nicola Savill
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	SAGE Publishing 2011-01-01
Reeks:	Journal of Central Nervous System Disease
Online toegang:	https://doi.org/10.4137/JCNSD.S4391

Gelijkaardige items

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
door: Chris J. Bushe MBBS, et al.
Gepubliceerd in: (2011-12-01)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
door: Clemow DB, et al.
Gepubliceerd in: (2017-02-01)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
door: Paul Hammerness, et al.
Gepubliceerd in: (2009-03-01)

A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?
door: Savill Nicola, et al.
Gepubliceerd in: (2012-01-01)

Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
door: Su Jin Moon, et al.
Gepubliceerd in: (2014-01-01)

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
door: Schacht Alexander, et al.
Gepubliceerd in: (2010-12-01)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
door: Tsutomu Nagai, et al.
Gepubliceerd in: (2022-09-01)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
door: Rubin Richard, et al.
Gepubliceerd in: (2009-12-01)

Effect of sluggish cognitive tempo on the efficacy of atomoxetine in children with attention-deficit/hyperactivity disorder
door: Wenjun WU, et al.
Gepubliceerd in: (2024-10-01)

Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder
door: Vijaya Kumar, et al.
Gepubliceerd in: (2017-01-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
door: Joseph A, et al.
Gepubliceerd in: (2016-03-01)

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
door: Reimherr Fred, et al.
Gepubliceerd in: (2005-10-01)

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
door: Cao P, et al.
Gepubliceerd in: (2018-11-01)

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
door: Serkan Turan, et al.
Gepubliceerd in: (2019-10-01)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
door: Ball Susan, et al.
Gepubliceerd in: (2007-09-01)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
door: Dilla Tatiana, et al.
Gepubliceerd in: (2009-04-01)

Attention-deficit/hyperactive disorder updates
door: Miriam Kessi, et al.
Gepubliceerd in: (2022-09-01)

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
door: S King, et al.
Gepubliceerd in: (2006-07-01)

An updated review on animal models to study attention-deficit hyperactivity disorder
door: Daegeon Kim, et al.
Gepubliceerd in: (2024-04-01)

Serotonin syndrome induced by overdose of atomoxetine alone in a patient with attention‐deficit hyperactivity disorder: A case report
door: Fumika Sato, et al.
Gepubliceerd in: (2022-09-01)

Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World Setting
door: Ying Zhang, et al.
Gepubliceerd in: (2023-11-01)

Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder
door: Satoshi Kasahara, et al.
Gepubliceerd in: (2023-08-01)

Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders
door: Snircova E., et al.
Gepubliceerd in: (2012-12-01)

Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine
door: Satoshi Kasahara, et al.
Gepubliceerd in: (2022-07-01)

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
door: Imagawa H, et al.
Gepubliceerd in: (2018-02-01)

Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study
door: Huiya Mei, et al.
Gepubliceerd in: (2022-02-01)

Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function
door: Wilfried Pott, et al.
Gepubliceerd in: (2013-03-01)

Management of sleep disorders in autism spectrum disorder with co-occurring attention-deficit hyperactivity disorder: update for clinicians
door: Theodore Petti, et al.
Gepubliceerd in: (2024-01-01)

Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
door: Satoshi Kasahara, et al.
Gepubliceerd in: (2023-06-01)

Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
door: Turgay Atilla, et al.
Gepubliceerd in: (2011-05-01)

A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy
door: Jeff Schein, et al.
Gepubliceerd in: (2024-08-01)

Atomoxetine Treatment of Attention Deficit/Hyperactivity Disorder Symptoms in 3–6-Year-Old Children with Autism Spectrum Disorder: A Retrospective Cohort Study
door: Hamza A. Alsayouf, et al.
Gepubliceerd in: (2024-01-01)

Clinical practice guidelines for attention-deficit/hyperactivity disorder: recent updates
door: Tae Hoon Eom, et al.
Gepubliceerd in: (2024-01-01)

Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): an update on the controversies
door: Johnston Josephine, et al.
Gepubliceerd in: (2009-01-01)

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review
door: Katya Rubia, et al.
Gepubliceerd in: (2021-08-01)

A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD)
door: Yuyang Luo, et al.
Gepubliceerd in: (2019-02-01)

Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
door: Jadwiga Najib, et al.
Gepubliceerd in: (2017-08-01)

Attention deficit hyperactivity disorder.
door: Ramchandani, P, et al.
Gepubliceerd in: (2003)

Attention deficit/hyperactivity disorder /
door: Dudley, William, 1964-
Gepubliceerd in: (2005)

Attention-deficit/hyperactivity disorder
door: A. M.E. du Plessis
Gepubliceerd in: (2015-05-01)